机译:转移性肾细胞癌靶向治疗的治疗药物监测
Hunan Canc Hosp Dept Pharm Changsha Hunan Peoples R China;
Hunan Canc Hosp Dept Pharm Changsha Hunan Peoples R China;
Hunan Canc Hosp Dept Pharm Changsha Hunan Peoples R China;
Hunan Canc Hosp Dept Pharm Changsha Hunan Peoples R China;
Hunan Canc Hosp Dept Pharm Changsha Hunan Peoples R China;
Hunan Canc Hosp Dept Pharm Changsha Hunan Peoples R China;
Hunan Canc Hosp Dept Pharm Changsha Hunan Peoples R China;
Cent S Univ Xiangya Hosp 2 Dept Pharm Changsha Hunan Peoples R China;
Hunan Canc Hosp Dept Lung Canc &
Gastroenterol Changsha Hunan Peoples R China;
mRCC; TDM; targeted therapies; inter-individual pharmacokinetics; molecular mechanism; exposure and response relationship;
机译:转移性肾细胞癌靶向治疗的治疗药物监测
机译:序贯分子靶向药物治疗,包括阿昔替尼,用于晚期肾衰竭和转移性肾细胞癌患者
机译:户外毒素治疗药物监测在成人中胃肠道基质肿瘤和转移性肾细胞癌 - 评论
机译:何时治疗转移性肾细胞癌的组合,全身治疗,以及在转移性肾癌中的活跃监测
机译:肿瘤多组分靶向聚合物 - 脂质杂化纳米颗粒,以克服肾细胞癌的耐药性
机译:靶向治疗治疗的转移性非透明细胞肾细胞癌的生存和临床预后因素:使用韩国转移性肾细胞癌登记系统的多机构回顾性研究
机译:靶向治疗治疗转移性非透明细胞肾细胞癌中的存活和临床预后因素:使用韩国转移性肾细胞癌登记处的多机构,回顾性研究